Psychemedics Corporation (NASDAQ: PMD) today announced that it has signed a sales and marketing agreement with LGC of the UK, an international science-based company and market leader in analytical, forensic and diagnostic services and reference standards, to market the patented Psychemedics hair analysis drug test in the UK and Europe.
